A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B Hsu, Y., Tanaka, Y., Nguyen, M., Chang, C., Tai, C., Tseng, C., Chen, C., Wu, M., Lin, J. ELSEVIER SCIENCE BV. 2018: S498

View details for DOI 10.1016/S0168-8278(18)31243-1

View details for Web of Science ID 000461068602210